Pharmacolog expands into China with Codonics
Pharmacolog and Codonics extend existing agreement to include sales of WasteLog® in the Chinese market.
Warrants of series TO1 were subscribed to approximately 94.1 percent and Pharmacolog i Uppsala AB (publ) receives approximately SEK 21.4 million
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, ...
TriHealth Good Samaritan Hospital choose WasteLog®
Pharmacolog’s partner, Codonics, to deliver leading Ohio hospital with WasteLog® to assist with drug diversion prevention initiative.
Members of the board of directors and the management team of Pharmacolog exercise all held warrants of series TO1 for approximately SEK 1.47 million
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, AUSTRALIA, CANADA, ...
The last day of trading with the warrants of series TO1 in Pharmacolog i Uppsala AB (publ) is August 13, 2021
Interim report January – June 2021
Press release: Uppsala, August 12, 2021. Pharmacolog i Uppsala AB’s (publ) interim report for the period January – June is ...
The exercise period for warrants of series TO1 begins today
The exercise price for the warrants of series TO1 in Pharmacolog i Uppsala AB (publ) has been determined to SEK 8,06 per share
Pharmacolog and Codonics® Expand Relationship
Pharmacolog and Codonics extend exclusive U.S. and Canadian distributor agreement to include DrugLog® in addition to WasteLog®
DrugLog® ready for launch in the US
Pharmacolog has registered DrugLog® with the US Food and Drug Administration (FDA) and can thereby sell and deliver systems to ...